Sign In
Buy HCAT
$2.09
+0.0100 (+0.481%)
At Close: Jul 31, 2026
What's in the Cards for CVS Health (CVS) in Q1 Earnings?
03:37pm, Friday, 01'st May 2020
We expect CVS Health (CVS) to have gained from Aetna's addition of new Individual and Group Medicare Advantage members in Q1.
What's in the Cards for CVS Health (CVS) in Q1 Earnings?
03:37pm, Friday, 01'st May 2020
We expect CVS Health (CVS) to have gained from Aetna's addition of new Individual and Group Medicare Advantage members in Q1.
What will the Oracle say?
09:05am, Friday, 01'st May 2020
News is free at Seeking Alpha.This post is a Notable Call. Notable Calls are a Premium feature.To access this and other Notable Calls, try a free trial to Seeking Alpha Premium.
Gives His Opinion On GM, American Airlines And More
01:44pm, Wednesday, 29'th Apr 2020
On CNBC's "Mad Money Lightning Round," Jim Cramer said Prudential Financial's (NYSE: PRU) payout is too high and that concerns him. In his career, when he tried to reach for yield, he was rarely right
Health Catalyst to Announce First Quarter 2020 Operating Results and Host Conference Call on Tuesday, May 12, 2020
08:15pm, Tuesday, 28'th Apr 2020
SALT LAKE CITY, April 28, 2020 -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare.
SunTrust Robinson Sticks to Its Buy Rating for Health Catalyst (HCAT)
06:53pm, Wednesday, 22'nd Apr 2020
SunTrust Robinson analyst Sandy Draper maintained a Buy rating on Health Catalyst (HCAT) today and set a price target of $30.00. The company's shares
SunTrust Robinson Sticks to Its Buy Rating for Health Catalyst (HCAT)
06:53pm, Wednesday, 22'nd Apr 2020
SunTrust Robinson analyst
Sandy Draper
maintained a
Buy
rating on Health Catalyst (
HCAT
–
Research Report
) today and set a price target of
$30.00
. The company’s shares closed last Wednesday at
Health Catalyst (HCAT) Receives a Buy from Cantor Fitzgerald
06:52pm, Wednesday, 22'nd Apr 2020
In a report issued on April 20, Steven Halper from Cantor Fitzgerald reiterated a Buy rating on Health Catalyst (HCAT), with a price target of $44.00. The
Health Catalyst (HCAT) Receives a Buy from Cantor Fitzgerald
06:52pm, Wednesday, 22'nd Apr 2020
In a report issued on April 20, Steven Halper from Cantor Fitzgerald reiterated a Buy rating on Health Catalyst (HCAT
Health Catalyst (HCAT) Receives a Buy from RBC Capital
03:56pm, Wednesday, 22'nd Apr 2020
In a report issued on April 20, Sean Dodge from RBC Capital maintained a Buy rating on Health Catalyst (HCAT), with a price target of $30.00. The
Health Catalyst (HCAT) Receives a Buy from RBC Capital
03:56pm, Wednesday, 22'nd Apr 2020
In a report issued on April 20, Sean Dodge from RBC Capital maintained a Buy rating on Health Catalyst (HCAT
UBS softens view on Eli Lilly in premarket analyst action
11:14am, Tuesday, 21'st Apr 2020
Allscripts Healthcare Solutions (NASDAQ:MDRX) initiated with an Outperform rating and an $8 (21% upside) price target at RBC.Aprea Therapeutics (NASDAQ:APRE) initiated with an Outperform rating and a
Health Catalyst National Data Repository Helps Clients Battle COVID-19
12:24pm, Monday, 20'th Apr 2020
Healthcare providers and public health authorities across the country are struggling to answer complex questions related to the COVID-19 pandemic. Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCA
Health Catalyst and Carle Health Partner to Improve Patient Care with Data and Analytics Solutions
12:00pm, Tuesday, 14'th Apr 2020
Carle Health today joined Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, in announcing a five ye
Leerink rolls out lineup of bullish calls in premarket analyst action
11:51am, Monday, 13'th Apr 2020
Allogene Therapeutics (NASDAQ:ALLO) initiated with Buy rating and $29 (28% upside) price target at SunTrust.Allscripts Healthcare Solutions (NASDAQ:MDRX) initiated with Market Perform rating and $8 (1
